Full Text (PDF)
Original Article

Evaluation in Supraclavicular Brachial Plexus Block between Dexmedetomidine and dexamethasone as an Adjuvant to Local Anesthetic: A Double-Blind Prospective Study

Kiran Kumar T , Thomas P George1 , Kiran Kumar T2 , Joe Joseph3

Author Information

Licence:




Indian Journal of Anesthesia and Analgesia 6(5):p 1659-1664, September-October 2019. | DOI: http://dx.doi.org/10.21088/ijaa.2349.8471.6519.26

How Cite This Article:

Thomas P George, Kiran Kumar T, Joe Joseph. Evaluation in Supraclavicular Brachial Plexus Block between Dexmedetomidine and dexamethasone as an Adjuvant to Local Anesthetic: A Double-Blind Prospective Study. Indian J Anesth Analg. 2019;6(5 Part-1):1659-1664.


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Background: Supraclavicular brachial plexus block is a commonly employed regional nerve block technique for upper extremity surgery. Various adjuvants were added tolocal anesthetics in brachial plexus block to achieve rapid onset and prolonged block. Objective: To compare dexamethasone and dexmedetomidine as an adjuvant to local anesthetic agent in supraclavicular brachial plexus block with respect to onset and duration of sensory and motor block. Methods: Forty ASA I and II patients scheduled for elective upper limb surgeries under supraclavicular brachial plexus block were divided into two equal groups in a double-blinded fashion. Group one was given 0.25% Bupivacaine 2 milligram/kg aslocal anesthetic and Dexmedetomidine 1 microgram/kg as adjuvant. Group two was given 0.25% Bupivacaine 2 milligram/kg and Dexamethasone 100 microgram/kg as adjuvant. Onset and duration of sensory and motor blockade and hemodynamic stability were recorded. All patients were observed for any side effects and complications. All data were recorded, and statistical analysis was done. Results: Sensory block and motor block onset was earlier in dexmedetomidine group. The duration of blockade was also prolonged in dexmedetomidine group when compared with dexamethasone group and is not associated with any major side-effect. Conclusion: Dexmedetomidine is a better adjuvant than dexamethasone in supraclavicular brachial plexus block.


References

No records found.


About this article


Cite this article

Thomas P George, Kiran Kumar T, Joe Joseph. Evaluation in Supraclavicular Brachial Plexus Block between Dexmedetomidine and dexamethasone as an Adjuvant to Local Anesthetic: A Double-Blind Prospective Study. Indian J Anesth Analg. 2019;6(5 Part-1):1659-1664.


Licence:




Received Accepted Published
N/A N/A N/A

DOI: http://dx.doi.org/10.21088/ijaa.2349.8471.6519.26

Keywords

Dexmedetomidine; Dexamethasone; Bupivacaine; Supraclavicular brachialplexus block.

Article Level Metrics

Last Updated

Monday 13 July 2026, 06:43:36 (IST)


5648

Accesses

3
678
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share